Endoscopic Management of Benign Airway Stenosis in Coronavirus Disease 2019 Patients
The Thoracic and Cardiovascular Surgeon · 01.06.2024 · 72 (04) · 320-325
DOI: 10.1055/a-2075-8109 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.06.2024. Verfasst von Alfonso Fiorelli und 6 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic Surgery Unit, Università della Campania "Luigi Vanvitelli", Naples, Italy. Hauptthemen laut MEDLINE: COVID-19, Recurrence, Dilatation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Background
The aims of this study were to evaluate the results of endoscopic dilation for simple benign airway stenosis in coronavirus disease 2019 (COVID-19) patients and whether COVID-19 infection was associated with higher rate of recurrence compared with a control group.
Methods
It was an observational multicenter study including consecutive patients with simple benign airway stenosis undergoing endoscopic dilatation with at least 6 months of follow-up. The outcome of patients with COVID-19 infection was compared with that of a control group in relation to patient and stenosis characteristics, and procedure type. Then, univariable and multivariable analyses identified the risk factors for recurrence.
Results
Seventy-nine patients were included in the study; 56 (71%) of these developed airway stenosis after COVID-19 infection. COVID-19 patients presented a higher rate of stenosis due to prolonged intubation (82 vs. 43%; p = 0.0014); no other differences were found regarding demographic data, characteristics of stenosis, and procedure type. Twenty-four (30%) patients had recurrence after first dilatation (32% for No-COVID-19 vs. 26% for COVID-19 group; p = 0.70), and in 11 (35%) of these, the stenosis recurred after repeated endoscopic treatment (65% for No-COVID-19 vs. 45% for COVID-19 group; p = 0.40). Subglottic stenosis (p = 0.013) and the use of laser (p = 0.016) were significant predictive factors for stenosis recurrence.
Conclusion
COVID-19 infection did not affect the outcome of endoscopic treatment of simple airway stenosis, and the treatment of these subsets of patients should not differ from that of general population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Thoracic Surgery Unit, Università della Campania "Luigi Vanvitelli", Naples, Italy.
- Bronchoscopy Unit, Ospedale Cardarelli, Napoli, Campania, Italy.
- Respiratory Medicine and Pulmonary Rehabilitation Unit, Clinic Center, Naples, Italy.
- Thoracic Surgery Unit, Università degli Studi di Roma La Sapienza, Rome, Lazio, Italy.
ORCID-Profile: Alfonso Fiorelli
Zitieren
APA
Fiorelli, A., Pecoraro, A., Failla, G., Blasio, F., Rendina, E. A., Venuta, F., & Andreetti, C. (2024). Endoscopic Management of Benign Airway Stenosis in Coronavirus Disease 2019 Patients. The Thoracic and Cardiovascular Surgeon, 72(04), 320-325. https://doi.org/10.1055/a-2075-8109
Vancouver
Fiorelli A, Pecoraro A, Failla G, Blasio F, Rendina EA, Venuta F, et al. Endoscopic Management of Benign Airway Stenosis in Coronavirus Disease 2019 Patients. The Thoracic and Cardiovascular Surgeon. 2024;72(04):320-325. doi:10.1055/a-2075-8109
BibTeX
@article{Fiorelli2024,
author = {Fiorelli, Alfonso and Pecoraro, Alfonso and Failla, Giuseppe and Blasio, Francesco De and Rendina, Erino Angelo and Venuta, Federico and Andreetti, Claudio},
title = {Endoscopic Management of Benign Airway Stenosis in Coronavirus Disease 2019 Patients},
journal = {The Thoracic and Cardiovascular Surgeon},
year = {2024},
volume = {72},
number = {04},
pages = {320--325},
doi = {10.1055/a-2075-8109}
}
EUVIMED